Is Palvella Therapeutics, Inc. (PVLA) a Buy, Sell, or Hold?
NASDAQ : PVLA
Palvella Therapeutics, Inc. — Competitors
$143 USD
$0.16 (0.11%)
- Volume
- 55.73K
- Average Volume
- 268.7K
- Market Capitalization
- $2.05B
- P/E Ratio
- -34.29
- Dividend Yield
- 0.00%
- Price Target
- $220.00
- Year High
- $161.38
- Year Low
- $34.57
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $28.88
PVLA vs. The Competition
| Properties | PVLA | ABUS | EYPT | GHRS |
|---|---|---|---|---|
| Market Cap | $2.05B | $847.44M | $986.81M | $1.94B |
| Shares Outstanding | $14.34M | $197.54M | $83.84M | $68.56M |
| P/E Ratio | -34.29 | 5.15 | -3.36 | -30.84 |
| EPS | -3.77 | 0.83 | -3.16 | -0.91 |
| Day Low | 139.42 | 4.27 | 11.57 | 27.335 |
| Day High | 145.41 | 4.43 | 12.11 | 28.38 |
| Year Low | 34.57 | 3.26 | 9.4 | 11.32 |
| Year High | 161.38 | 5.38 | 19.11 | 31 |
| Average Price 50 | 127.5567 | 4.5126 | 13.112 | 24.5454 |
| Average Price 200 | 108.41795 | 4.44735 | 14.11275 | 17.71038 |
| Volume | 55728.1 | 1.3M | 729.78K | 94368.82 |
| Average Volume | - | - | - | - |